HELP · Cybin Inc.
$7.60
-0.10 (-1.30%)
At close · Jul 28
Market Cap
$472.01M
Shares
61.98M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.60
Open$7.55
Day$7.35–7.66
52W$3.76–9.12
Avg vol 30d1.7M
Short int3.3M · 5.3% float · 2.9d
Short vol37%
DataJan 2020–Jul 2026
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+25%
above
Price vs 50-day avg
+37%
above
RSI (14)
65
neutral
MACD trend
Positive
52-week position
72%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+10%
trailing
6-month return
+14%
trailing
YTD return
−7%
this year
Relative strength
+7%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $6 — 200d above 50d
Institutional flow
Accumulating
18 of 82 funds reported for Jun 30 · net +17.5K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.25% of float · ▲ +8.7% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
82 holders — near 1-yr high, broad support
Squeeze score
66
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
81%
annualized · 1-yr
Max drawdown
−56%
past year
ATR
6.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+25%
Bullish
Price vs 50-day avg
+37%
Bullish
RSI (14)
65
Neutral
MACD trend
Positive
Bullish
52-week position
72%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $6 › 200d $6 — 200d above 50d
Institutional flow
Accumulating
18 of 82 funds reported for Jun 30 · net +17.5K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
5.25% of float · ▲ +8.7% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
82 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $4
Now $8 · 72%
52-wk high $9
vs 200-day avg +25%
vs 50-day avg +37%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HELP
this stock
Cybin Inc.
|
$472.01M | -7.1% | — | — | 5.3% |
|
ONC
BeOne Medicines Ltd.
|
$477.60B | +7.3% | +22179.2% | 971.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$124.46B | +8.2% | +46.2% | 29.1 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.88B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$54.57B | +3.7% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HELP | -6.2% | +10.5% | +14.5% | +15.0% | -7.1% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | -5.2% | +10.5% | +7.0% | +15.8% | -15.7% |
Key facts
CIK
1833141
CUSIP
23256X407
13F (30d)
18 filings
18 filers
Visit website
Investor relations